Skip to main content

Table 4 Adverse events potentially related to compression bandages (max. 30 months)

From: The Canadian Bandaging Trial: Evidence-informed leg ulcer care and the effectiveness of two compression technologies

 

4LB

(n = 215)

SSB

(n = 209)

p-value

 

n (%)

n (%)

 

Pressure damage

15 (7.0)

13 (6.2)

0.85

Skin breakdown

27 (12.6)

34 (16.3)

0.33

Ulcer deterioration

27 (12.6)

32 (15.3)

0.48

Infection

28 (13.0)

35 (16.7)

0.34

New ulcer

13 (6.0)

22 (10.5)

0.11

Allergy/dermatitis related to bandaging

15 (7.0)

14 (6.7)

1.00

Allergy/dermatitis related to ointment/cream

9 (4.2)

10 (4.8)

0.82

Recurrence

2 (0.9)

5 (2.4)

0.28

Limb compromise

2 (0.9)

2 (1.0)

1.00

Total

138 (64.2)

167 (80.0)

Â